Global Medical REIT price target lowered to $9.50 from $11 at Alliance Global Partners

Alliance Global Partners analyst Gaurav Mehta lowered the firm’s price target on Global Medical REIT (GMRE) to $9.50 from $11 and keeps a Buy rating on the shares. While there was a decline in occupancy in Q1 and management comments indicate that there could be further decline in occupancy in Q2 and Q3, the company noted that there could be improvement by the end of 2025, the analyst tells investors in a research note. The firm believes that an improved portfolio performance could be a positive catalyst for the stock, adding that it views the current valuation as attractive and believes risk/reward is skewed to the upside at current pricing.